ArticleBrain behavior and immunity integrative2026
Orchestrating neuroinflammation: A symphony of Interleukin-1 and cell type-specific Interleukin-1 receptor type 1 signaling in the brain.
Article in Brain behavior and immunity integrative, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Interleukin-1 (IL-1) was one of the first inflammatory cytokines to be discovered in the peripheral immune system. It is a master regulator of the inflammatory responses to infection and injury in the entire body. Infection and injury to the central nervous system (CNS) inevitably activate the IL-1 system similar to the periphery. While the existence of inflammation in the CNS, neuroinflammation, is not surprising, the CNS represents a unique structure-functional entity that requires special consideration for the understanding of the role of the IL-1 system in the brain. First, the presence of the blood-brain barrier (BBB) restricts the entry of many immune signal molecules and cells from easy access to the brain, preventing undesirable consequences of peripheral style of inflammation (swelling, for example) that could overwhelm the finite space of the brain; second, the presence of brain specific cell types-neurons, astrocytes, microglia, oligodendrocytes, ventricular ependymal cells, and choroid plexus cells-suggests IL-1 system may conduct neuroinflammation differently in this special environment through these cell types; third, recent studies have revealed that IL-1 can directly modulate neural circuitry and function and the subsequent neuroimmune crosstalk impacts neuroinflammation, neural function, and behavior, expanding the role of the IL-1 system into the realm of neurobiology. This mini-review summarizes the current state of knowledge about how the CNS IL-1 system might regulate neuroinflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.